The Global Digital Diabetes Management Market is accounted for USD 4,464.8 million in 2017 and expected to register ~ 23.7 % CAGR during the forecast period (2018–2023).
The digital diabetes management provide a platform that simplify the tracking of diabetes data. It helps Type 1 and Type 2 diabetes patients to manage blood test results from a glucose meter, records of actual insulin delivery, statistical evaluation.
The increasing prevalence of diabetes, technological advancements, rising demand for selfcare, and involvement of major players in product launch, collaboration, and strategic merger & acquisitions are the major factors driving the growth of the global digital diabetes management market. Additionally, increasing research and development spending by the top players are fueling the growth of the market during forecast period. For instance, in 2017,
Fill out Details to Receive FREE Sample Here: https://www.marketresearchfuture.com/sample_request/7527

Key Players
Some of the key players in the global digital diabetes management market are, Dariohealth Corporation, Dexcom, Inc., F. Hoffmann-La Roche, Glooko, Inc., Insulet Corporation, Lifescan, Inc., Medtronic PLC, Tandem Diabetes Care, Inc., Tidepool, and others.

Medtronic introduce MiniMed 670G first hybrid closed loop system for type 1 diabetes patients. Also, in 2018, Roche Diagnostics and Wellthy Therapeutics Private Limited (India) signed a partnership for offering an artificial intelligence-based digital diabetes coaching solution for users of the Accu-Chek Active system.
However, the high cost associated with homecare devices and lack of awareness may hamper the growth of the market during the assessment period.